Johnson & Johnson Reports 5.3% Sales Growth and $32B Investment in 2025
Johnson & Johnson's CEO, Joaquin Duato, highlighted strong financial performance and strategic investments during the 2026 annual meeting, reporting 5.3% operational sales growth and $32 billion in R&D and acquisition investments. The company also announced $26.2 billion in adjusted net earnings and plans to invest $55 billion in the U.S. by early 2029.
Tickers: $JNJ
Topics: annual meeting CEO statement governance Johnson & Johnson product launches R&D investment